000042100 000__ 01333cam\a22002535i\4500
000042100 001__ 42100
000042100 003__ SzGeWIPO
000042100 005__ 20240708145900.0
000042100 008__ 200625s2020\\\\sz\\\\\\r\\\\\000\0\eng\d
000042100 040__ $$aSzGeWIPO$$beng$$erda
000042100 041__ $$aeng
000042100 1001_ $$aHaney, Brian S.
000042100 24503 $$aA Law and Economics Perspective on Dermatological Disease
000042100 264_1 $$a[S.l. :$$bs.n.],$$c2020.
000042100 300__ $$a57 pages
000042100 336__ $$atext$$btxt$$2rdacontent
000042100 337__ $$aunmediated$$bn$$2rdamedia
000042100 338__ $$avolume$$bnc$$2rdacarrier
000042100 520__ $$aThe human population is infested with dermatological diseases. For example, at a global scale, 95% of people are infected with the Herpes Simplex Virus (HSV) and 90% of people contract the Human Papillomavirus (HPV) in their lifetime. Yet, while the healthcare law literature is visibly scaling, the research relating to the law and economic systems controlling treatment for ubiquitous dermatological disease is non-existent.  First, this Article explains the biological understructure for common dermatological diseases. Second, this Article introduces a novel dataset sampling dermatology patents and providing market models, legal claims analysis, and valuation guidelines. Third, this paper discusses future dermatological technologies and regulatory access issues.
000042100 542__ $$aCC BY NC 3.0
000042100 650__ $$aLaw and Economics
000042100 650_0 $$aHealthcare Law
000042100 650_0 $$aDermatology
000042100 650_0 $$aPharmaceutical Patents
000042100 85641 $$uhttps://papers.ssrn.com/sol3/papers.cfm?abstract_id=3631357$$yView this resource
000042100 904__ $$aJournal article
000042100 980__ $$aBIB